載入...
An Investigation on a Novel Anti-tumor Fusion Peptide of FSH(33-53)-IIKK
A novel fusion peptide FSH(33-53)-IIKK was designed and expected to combine the follicle stimulating hormone receptor (FSHR) targeting and tumor toxicity. In vitro and in vivo study showed the anti-tumor activity of FSH(33-53)-IIKK was enhanced compared to that of IIKK only. FSH(33-53)-IIKK could in...
Na minha lista:
| 發表在: | J Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Ivyspring International Publisher
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910594/ https://ncbi.nlm.nih.gov/pubmed/27313792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.14425 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|